StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.81+0.03 (+0.63%)

Close on Nov 18, 2026Market cap $60.26MP/E 12.0Yield 3.85%

Lifevantage revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Lifevantage's revenue for the twelve months ending Jun 30, 2026 was $182.59M, down 20.1% year over year. For fiscal 2026 it was $182.59M, down 20.1% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is $232.92M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$182.59M-20.1%
FY2025Jun 30, 2025$228.53M+14.2%
FY2024Jun 30, 2024$200.16M-6.2%
FY2023Jun 30, 2023$213.40M+3.4%
FY2022Jun 30, 2022$206.36M-6.3%
FY2021Jun 30, 2021$220.18M-5.5%
FY2020Jun 30, 2020$232.92M+3.1%
FY2019Jun 30, 2019$225.96M+11.2%
FY2018Jun 30, 2018$203.20M+1.9%
FY2017Jun 30, 2017$199.49M-3.4%
FY2016Jun 30, 2016$206.54M+8.5%
FY2015Jun 30, 2015$190.34M-11.0%
FY2014Jun 30, 2014$213.97M+2.8%
FY2013Jun 30, 2013$208.18M+65.0%
FY2012Jun 30, 2012$126.18M+224.2%
FY2011Jun 30, 2011$38.92M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$42.38M-23.1%
Q3 FY2026CQ1 2026Mar 31, 2026$43.72M-25.2%
Q2 FY2026CQ4 2025Dec 31, 2025$48.93M-27.8%
Q1 FY2026CQ3 2025Sep 30, 2025$47.56M+0.7%
Q4 FY2025CQ2 2025Jun 30, 2025$55.11M+12.6%
Q3 FY2025CQ1 2025Mar 31, 2025$58.44M+21.1%
Q2 FY2025CQ4 2024Dec 31, 2024$67.76M+31.3%
Q1 FY2025CQ3 2024Sep 30, 2024$47.21M-8.1%
Q4 FY2024CQ2 2024Jun 30, 2024$48.93M-9.8%
Q3 FY2024CQ1 2024Mar 31, 2024$48.25M-10.2%
Q2 FY2024CQ4 2023Dec 31, 2023$51.62M-3.8%
Q1 FY2024CQ3 2023Sep 30, 2023$51.36M-0.8%
Q4 FY2023CQ2 2023Jun 30, 2023$54.22M+6.4%
Q3 FY2023CQ1 2023Mar 31, 2023$53.74M+7.5%
Q2 FY2023CQ4 2022Dec 31, 2022$53.66M+2.8%
Q1 FY2023CQ3 2022Sep 30, 2022$51.77M-2.7%
Q4 FY2022CQ2 2022Jun 30, 2022$50.94M-7.0%
Q3 FY2022CQ1 2022Mar 31, 2022$50.00M-3.0%
Q2 FY2022CQ4 2021Dec 31, 2021$52.19M-11.6%
Q1 FY2022CQ3 2021Sep 30, 2021$53.22M-2.9%
Q4 FY2021CQ2 2021Jun 30, 2021$54.78M-7.7%
Q3 FY2021CQ1 2021Mar 31, 2021$51.57M-8.0%
Q2 FY2021CQ4 2020Dec 31, 2020$59.01M-3.6%
Q1 FY2021CQ3 2020Sep 30, 2020$54.83M-2.5%
Q4 FY2020CQ2 2020Jun 30, 2020$59.37M+5.7%
Q3 FY2020CQ1 2020Mar 31, 2020$56.08M+0.1%
Q2 FY2020CQ4 2019Dec 31, 2019$61.24M+5.3%
Q1 FY2020CQ3 2019Sep 30, 2019$56.23M+1.1%
Q4 FY2019CQ2 2019Jun 30, 2019$56.17M+4.0%
Q3 FY2019CQ1 2019Mar 31, 2019$56.01M+10.8%
Q2 FY2019CQ4 2018Dec 31, 2018$58.17M+17.6%
Q1 FY2019CQ3 2018Sep 30, 2018$55.61M+13.2%
Q4 FY2018CQ2 2018Jun 30, 2018$54.03M+6.7%
Q3 FY2018CQ1 2018Mar 31, 2018$50.56M+12.3%
Q2 FY2018CQ4 2017Dec 31, 2017$49.48M+1.1%
Q1 FY2018CQ3 2017Sep 30, 2017$49.13M-10.5%
Q4 FY2017CQ2 2017Jun 30, 2017$50.64M–
Q3 FY2017CQ1 2017Mar 31, 2017$45.01M–
Q2 FY2017CQ4 2016Dec 31, 2016$48.95M–
Q1 FY2017CQ3 2016Sep 30, 2016$54.89M–

More Lifevantage figures

See a number that looks wrong?